Biofrontera Inc. Common Stock BFRI · Stock Open Biofrontera Inc. Common Stock in new tab
Biofrontera Inc. Common Stock Analysis (BFRI)
Is Biofrontera Inc. Common Stock a good investment? Biofrontera Inc. Common Stock (BFRI) is currently trading at 1.04 USD. Market analysts have a consensus price target of 6.00 USD. This suggests a potential upside from current levels.
Earnings Schedule: Biofrontera Inc. Common Stock is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is 0.43.
Investor FAQ
Does Biofrontera Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Biofrontera Inc. Common Stock?
Biofrontera Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -0.43.
Company Profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
| Split Date | Split Ratio to 1 |
|---|---|
| July 5, 2023 | 1:20 |
Community Discussion